# To Explore the Pharmacokinetics and Relative Bioavailability of Sulfatinib Capsules in Two Different Manufacturers

> **NCT03483259** · PHASE1 · COMPLETED · sponsor: **Hutchison Medipharma Limited** · enrollment: 30 (actual)

## Conditions studied

- Relative Bioavailability

## Interventions

- **DRUG:** Sulfatinib T capsule
- **DRUG:** Sulfatinib R capsule

## Key facts

- **NCT ID:** NCT03483259
- **Lead sponsor:** Hutchison Medipharma Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-02
- **Primary completion:** 2018-05-12
- **Final completion:** 2018-05-18
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03483259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03483259, "To Explore the Pharmacokinetics and Relative Bioavailability of Sulfatinib Capsules in Two Different Manufacturers". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03483259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*